These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27781497)

  • 1. Solvents effects on crystallinity and dissolution of β-artemether
    Xu J; Singh V; Yin X; Singh P; Wu L; Xu X; Guo T; Sun L; Gui S; Zhang J
    Drug Dev Ind Pharm; 2017 Mar; 43(3):372-378. PubMed ID: 27781497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic properties and dissolution profile of efavirenz due to solvents recrystallization.
    Wardhana YW; Soewandhi SN; Wikarsa S; Suendo V
    Pak J Pharm Sci; 2019 May; 32(3):981-986. PubMed ID: 31278710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
    Bukovec P; Benkic P; Smrkolj M; Vrecer F
    Pharmazie; 2016 May; 71(5):263-8. PubMed ID: 27348970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
    Tran TT; Tran PH; Park JB; Lee BJ
    Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol.
    Sai Gouthami K; Kumar D; Thipparaboina R; Chavan RB; Shastri NR
    Int J Pharm; 2015 Aug; 491(1-2):26-34. PubMed ID: 26068197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal modification of dipyridamole using different solvents and crystallization conditions.
    Adhiyaman R; Basu SK
    Int J Pharm; 2006 Sep; 321(1-2):27-34. PubMed ID: 16842943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal modification of phenytoin using different solvents and crystallization conditions.
    Nokhodchi A; Bolourtchian N; Dinarvand R
    Int J Pharm; 2003 Jan; 250(1):85-97. PubMed ID: 12480275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved physicochemical characteristics of artemisinin using succinic acid.
    Ansari MT; Pervez H; Shehzad MT; Saeed-ul-Hassan S; Mehmood Z; Shah SN; Razi MT; Murtaza G
    Acta Pol Pharm; 2014; 71(3):451-62. PubMed ID: 25265825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
    Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine solvates.
    Cavallari C; Santos BP; Fini A
    J Pharm Sci; 2013 Nov; 102(11):4046-56. PubMed ID: 23963777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of solubility, dissolution and stability profile of artemether solid dispersions and self emulsified solid dispersions by solvent evaporation method.
    Tayyab Ansari M; Arshad MS; Hussain A; Ahmad Z
    Pharm Dev Technol; 2018 Dec; 23(10):1007-1015. PubMed ID: 27885872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
    Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of casting solvent on crystallinity of ondansetron in transdermal films.
    Pattnaik S; Swain K; Mallick S; Lin Z
    Int J Pharm; 2011 Mar; 406(1-2):106-10. PubMed ID: 21237257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocrystal habit engineering to improve drug dissolution and alter derived powder properties.
    Serrano DR; O'Connell P; Paluch KJ; Walsh D; Healy AM
    J Pharm Pharmacol; 2016 May; 68(5):665-77. PubMed ID: 26408342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of processing methods on the dissolution of artemether from two non-ordered mesoporous silicas.
    Tahir H; Shahzad Y; Waters LJ; Hussain T; Yousaf AM; Mahmood T; Sheikh R
    Eur J Pharm Sci; 2018 Jan; 112():139-145. PubMed ID: 29166624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Study on Dissolution Enhancement of Acetaminophen by Cooling, Anti-solvent, and Solvent Evaporation Crystallization.
    Chen R; Wang X; Liu W; Zhang K; Li Y; Wei Z
    AAPS PharmSciTech; 2017 Jan; 18(1):224-230. PubMed ID: 26961968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal modifications and dissolution rate of piroxicam.
    Lyn LY; Sze HW; Rajendran A; Adinarayana G; Dua K; Garg S
    Acta Pharm; 2011 Dec; 61(4):391-402. PubMed ID: 22202198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
    Javadzadeh Y; Mohammadi A; Khoei NS; Nokhodchi A
    Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced dissolution rate of simvastatin using spherical crystallization technique.
    Varshosaz J; Tavakoli N; Salamat FA
    Pharm Dev Technol; 2011 Oct; 16(5):529-35. PubMed ID: 20684739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.